Skip to content
Search

Latest Stories

HS2 Leeds branch cancelled: what will this mean for the north of England?

HS2 Leeds branch cancelled: what will this mean for the north of England?

FOLLOWING leaked reports that the British government would be scrapping plans for the UK’s long-awaited high-speed rail network to extend to Leeds, transport secretary Grant Shapps has announced in the House of Commons that the eastern leg of HS2 will now reach only from Birmingham to the East Midlands.

He said an additional high-speed line between Leeds and Manchester would no longer be built.


Instead, the newly published Integrated Rail Plan for the North and the Midlands sets out proposals to upgrade existing lines to reduce journey times between the cities sooner (although not by as much).

This contrasts with previous statements made in February 2020 committing the government to building the full HS2 network. It also leaves a substantial section of the north of England without a high-speed rail connection to the rest of the country.

Colin Bamford, economist and emeritus professor of transport and logistics at the University of Huddersfield, was asked what this would mean for the region.

Is the government correct in claiming that the new rail plan will deliver benefits to passengers in Yorkshire and the northeast – faster rail journeys in particular – much earlier and for a lot cheaper than the original HS2 plan?

The integrated rail plan brings forward local rail improvements by 10 years, which means that passengers looking to travel from Leeds to Manchester or Sheffield, say, will indeed benefit from shorter journey times a lot sooner than they would have done if they’d had to wait for HS2 to reach west Yorkshire.

It is a lot quicker to improve existing infrastructure than to build an entirely new system. But we knew that already: it was from the outset one of the arguments made by detractors of high-speed rail. HS2 was never just about quicker journey times.

What other crucial issues would have been solved by HS2 that the new plan must now address?

Capacity is the primary issue. The current east-coast mainline has no spare slots: because of the time that has to be allocated between each service, you couldn’t run more services on that line even if you wanted to. The idea of HS2 was to take capacity off the current line and transfer it to the fast line, thereby freeing up more capacity. The new plan will be useless if it doesn’t make it possible to increase the number of possible journeys.

Further, there is the question of what will happen with freight. The aim with HS2 was to transfer passenger traffic to the new line, thereby releasing slots for freight. Rail freight has repeatedly been shown to be a lot more sustainable and environmentally friendly.

Why were you in favour of HS2?

Though initially sceptical about the project due to the cost involved and questions over who would be able to use it, back in 2013 I came round to the benefits it would bring for the region as a whole. It would effectively bring us well into the 21st century. Business leaders argued it would provide more jobs and more investment.

HS2 is a prestige project. Its very construction and operation would have given the northeast of England a much better feel, psychologically and economically. Other parts of the country have a more superior rail system. The new Northern Powerhouse Rail plan between Leeds and Manchester is simply upgrading track that has been neglected for decades.

Government transport spending per capita in the Yorkshire and Humber region is half of what it is in Greater Manchester and one-fifth of what it is in London.

As an undergrad at Leeds University, I drew a map of what a rapid-transit system would look like and 40 years on, the city is still waiting for one. So the fact that funding for a new tram system has finally been promised is a sweetener. Leeds, to be sure, has changed dramatically in the last few years, but HS2 would have only accelerated that boom.

When you look at other European countries, from France to Italy, or countries in Asia, including South Korea, Taiwan, Japan and China, high-speed rail has a major bearing on those economies.

Is the cost-saving factor behind this decision justified?

The cost-benefit analysis for HS2 has never been convincing. When it first came out in 2013, the figures were questioned. There was a huge figure – £24.6 billion – in there for journey-time savings and a guesstimate too about the local economic impact, both of which were not convincing. As the cost of HS2 has gone up, the benefit to cost ratio has become increasingly unreliable.

The HS2 budget has indeed increased dramatically since the idea was first mooted, from £37.5 billion in 2011 to £110 billion in 2020, for it to be brought to completion including the full eastern leg. By contrast, prime minister Boris Johnson’s newly announced plan, which includes more than HS2 but not the full route to Leeds, comes with a £96 billion budget.

That is substantially less. Given the unprecedented costs accrued due to Covid, though, such cuts to government spending are understandable. And £96 billion still represents a major investment. Half a bar of chocolate is better than no chocolate.

(Reuters)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less